Annie Goodwin, Lina Karam, G S Gopalakrishna, Richard Kellermayer
{"title":"Selective lactase deficiency is common in pediatric patients undergoing upper endoscopy.","authors":"Annie Goodwin, Lina Karam, G S Gopalakrishna, Richard Kellermayer","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Lactase deficiency can lead to significant symptoms in the pediatric population. To date, few studies have examined the prevalence of enzyme testing-based lactase and other disaccharidase deficiencies (DDs) in pediatric patients undergoing upper endoscopic evaluation. The primary objective of this study was to determine the prevalence of selective lactase and other DDs amongst a large cohort of pediatric patients with and without inflammatory bowel disease (IBD: Crohn's disease and ulcerative colitis) via a chart review of 739 patients who underwent esophago-gastro-dudenoscopy EGD between April 2010 and August 2016. We identified 560 pediatric patients (ages 1-18 years) who underwent mucosal enzyme testing at the time of their EGD. The overall rate of lactase deficiency (LD) was 39%. LD positively correlated with age (p=0.00017), but there was no significant difference between age matched IBD and non-IBD patients (45% vs. 42% p=0.68). Four patients (0.17%) were found to have selective maltase deficiency. No selective sucrase or palatinase deficiency was identified. Statistically significant differences occurred in lactase deficiency amongst patients of different races. In conclusion, lactase deficiency is a relatively common finding in children undergoing EGD though at no increased rate amongst the IBD patient population. Disaccharidase testing should be considered in pediatric patients undergoing EGD.</p>","PeriodicalId":73836,"journal":{"name":"Journal of molecular biochemistry","volume":"7 1","pages":"41-47"},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481960/pdf/nihms-1022934.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of molecular biochemistry","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/5/31 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Lactase deficiency can lead to significant symptoms in the pediatric population. To date, few studies have examined the prevalence of enzyme testing-based lactase and other disaccharidase deficiencies (DDs) in pediatric patients undergoing upper endoscopic evaluation. The primary objective of this study was to determine the prevalence of selective lactase and other DDs amongst a large cohort of pediatric patients with and without inflammatory bowel disease (IBD: Crohn's disease and ulcerative colitis) via a chart review of 739 patients who underwent esophago-gastro-dudenoscopy EGD between April 2010 and August 2016. We identified 560 pediatric patients (ages 1-18 years) who underwent mucosal enzyme testing at the time of their EGD. The overall rate of lactase deficiency (LD) was 39%. LD positively correlated with age (p=0.00017), but there was no significant difference between age matched IBD and non-IBD patients (45% vs. 42% p=0.68). Four patients (0.17%) were found to have selective maltase deficiency. No selective sucrase or palatinase deficiency was identified. Statistically significant differences occurred in lactase deficiency amongst patients of different races. In conclusion, lactase deficiency is a relatively common finding in children undergoing EGD though at no increased rate amongst the IBD patient population. Disaccharidase testing should be considered in pediatric patients undergoing EGD.
在儿科人群中,乳糖酶缺乏可导致显著的症状。迄今为止,很少有研究调查了在接受上腔镜评估的儿科患者中基于酶检测的乳糖酶和其他双糖酶缺乏症(dd)的患病率。本研究的主要目的是通过对2010年4月至2016年8月期间接受食管-胃-肠镜检查的739例EGD患者的图表回顾,确定有和没有炎症性肠病(IBD:克罗恩病和溃疡性结肠炎)的儿童患者中选择性乳糖酶和其他DDs的患病率。我们确定了560名儿童患者(年龄1-18岁),他们在发生EGD时接受了粘膜酶检测。乳糖酶缺乏症(LD)总发生率为39%。LD与年龄呈正相关(p=0.00017),但年龄匹配的IBD与非IBD患者之间无显著差异(45% vs. 42% p=0.68)。选择性麦芽糖酶缺乏症4例(0.17%)。未发现选择性蔗糖酶或普氏酶缺乏症。不同种族患者的乳糖酶缺乏症差异有统计学意义。总之,乳糖酶缺乏症在EGD患儿中比较常见,但在IBD患者群体中没有增加。在接受EGD的儿科患者中应考虑进行双糖酶检测。